Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | NOS1 | P29475 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | NOS3 | P29474 | 1/20 | 0.41 |
| ▸ | NOS2 | P35228 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 2/20 | 0.41 |
| ▸ | MAOB | P27338 | 2/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 9/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.39 |
| ▸ | DRD1 | P21728 | 1/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.37 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23394119 | 0.88 | TP53 (0.44) | MEN1KMT2AIDO1TAAR1CYP1A2 | |
| SCHEMBL11779968 | 0.83 | MEN1 (0.44) | MEN1KMT2ANOS1CYP2D6NOS3 | |
| SCHEMBL6495105 | 0.83 | TAAR1 (0.63) | NOS1NOS3IDO1TAAR1DRD2 | |
| SCHEMBL6597028 | 0.83 | TAAR1 (0.63) | IDO1MAOBTAAR1 | |
| SCHEMBL7008701 | 0.83 | TAAR1 (0.63) | IDO1MAOBTAAR1 | |
| SCHEMBL6011479 | 0.83 | TAAR1 (0.63) | IDO1TAAR1 | |
| SCHEMBL11455165 | 0.83 | MEN1 (0.35) | MEN1KMT2ANOS1CYP2D6NOS3 | |
| SCHEMBL8760955 | 0.83 | DRD2 (0.63) | KMT2ATAAR1LMNADRD2DRD1 | |
| SCHEMBL6011770 | 0.83 | IDO1 (0.50) | MEN1KMT2ACYP2D6IDO1MAOA | |
| SCHEMBL7528532 | 0.82 | GABRA1 (0.40) | MEN1KMT2AMAOATAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 809 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12275813-B2 | Polymerizable composition for optical materials and application of same | MITSUI CHEMICALS, INC. (JP) | 2025-04-15 | — | — | US | claimed |
| EP-3581600-B1 | RESIN LENS AND PREPARATION METHOD THEREFOR | EFIRM NEW MAT CO LTD (CN) | 2025-01-08 | — | — | EP | claimed |
| CN-118745246-A | High refractive material based on biomass magnolol and honokiol | 中国科学院上海有机化学研究所 | 2024-10-08 | — | — | CN | claimed |
| US-11548971-B2 | Method for producing a resin lens from a polyisocyanate and release agent at reduced pressure | YIFENG NEW MATERIALS CO., LTD. (CN) | 2023-01-10 | — | — | US | claimed |
| US-11402755-B2 | Chemically amplified positive-type photosensitive resin composition, method for manufacturing substrate with template, and method for manufacturing plated article | TOKYO OHKA KOGYO CO., LTD. (JP) | 2022-08-02 | — | — | US | claimed |
| US-20210221940-A1 | RESIN LENS AND METHOD FOR PRODUCING THE SAME | SHANDONG EFIRM BIOCHEMISTRY AND ENVIRONMENTAL PROTECTION CO., LTD. (CN) | 2021-07-22 | — | — | US | claimed |
| EP-2963457-B1 | OPTICAL MATERIAL, COMPOSITION FOR USE THEREIN, AND USE THEREOF | MITSUI CHEMICALS INC (JP) | 2018-07-11 | — | — | EP | claimed |
| WO-2016050786-A1 | COSMETIC PROCESS FOR ATTENUATING WRINKLES | L'OREAL (FR) | 2016-04-07 | — | — | WO | claimed |
| US-6391433-B1 | — | — | None | — | — | US | disclosed |
| WO-2026105643-A1 | ISOCYANATE COMPOSITION, POLYMERIZABLE COMPOSITION, RESIN, MOLDED BODY, OPTICAL ELEMENT, AND LENS | 三井化学株式会社 | 2026-05-21 | — | — | WO | disclosed |
| WO-2026105644-A1 | ISOCYANATE COMPOSITION, POLYMERIZABLE COMPOSITION, RESIN, MOLDED BODY, OPTICAL ELEMENT, AND LENS | 三井化学株式会社 | 2026-05-21 | — | — | WO | disclosed |
| US-12606692-B2 | Spectacle lens | HOYA LENS THAILAND LTD. (TH) | 2026-04-21 | — | — | US | disclosed |
| EP-4725987-A2 | XYLYLENE DIISOCYANATE COMPOSITION, POLYMERIZABLE COMPOSITION, RESIN, MOLDED BODY, OPTICAL ELEMENT, AND LENS TECHNICAL FIELD | Mitsui Chemicals, Inc. (JP) | 2026-04-15 | — | — | EP | disclosed |
| US-20260062512-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | KUREHA CORPORATION (JP) | 2026-03-05 | — | — | US | disclosed |
| EP-0374258-A1 | HIGH REFRACTIVE INDEX LENS AND METHOD FOR ITS PRODUCTION | MITSUI CHEMICALS, INC. (JP) | 1990-06-27 | — | — | EP | disclosed |
| EP-0351073-A2 | Lens comprising a resin having a large refractive index and process for preparing the lens | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1990-01-17 | — | — | EP | disclosed |
| EP-0330363-A2 | Highly-refractive plastic lens and process for making the lens | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-08-30 | — | — | EP | disclosed |
| EP-0329387-A2 | Plastic lens, and method for its preparation | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-08-23 | — | — | EP | disclosed |
| EP-0050261-B1 | MOULDING MASSES STABILIZED AGAINST THERMOLYSIS WITH A LOW MONOMER CONTENT | BAYER AG (DE) | 1985-08-14 | — | — | EP | disclosed |
| EP-0050261-A1 | Moulding masses stabilized against thermolysis with a low monomer content | BAYER AG (DE) | 1982-04-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606692-B2 | Spectacle lens | POT1, TCOF1, CRY1 | MEN1 244/4885KMT2A 2800/4885NOS1 1347/4885 |
| US-20260062512-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | EHMT1, EHMT2, ASH2L | MEN1 4001/4885KMT2A 239/4885NOS1 1495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.